Skip to content

GLP-1 medication tracker

In Phase 3 trials

Retatrutide tracker

A private tracker for retatrutide — your weekly dose, your trend, yours.

Retatrutide is a next-generation weekly weight-loss injectable (a GLP-1, GIP, and glucagon agonist) in late-stage trials, with some of the largest weight-loss results reported so far. Whether you're in a trial or tracking it yourself, Lirea keeps a private, accurate record — on your device, with no account.

No account required. Nothing leaves your phone.

Today

Your shot day

This week

Retatrutide

weekly shot

Logged

Weight check-in

trend
Log a dose

What you'll track

Made for how you actually take Retatrutide.

A once-weekly injection (in clinical trials).

Never miss your weekly dose

Pick your day and Lirea reminds you before it's due, then logs it in one tap.

Follow your dose as it steps up

Retatrutide is taken at increasing doses over time. Lirea shows which step and week you're on, with easy holds and step-backs.

Weight as the outcome that matters

Watch your weight as a trend across months, and see how it moves as your dose climbs — without fixating on the daily number.

Side effects, in context

Log nausea, appetite changes, or anything else against your dose timing so the pattern is visible, not guesswork.

Why Lirea

Your Retatrutide data is nobody's business but yours.

No employer, insurer, or wellness platform ever sees what you log — and neither do we. It's stored and encrypted on your device, with no account and no server in the middle.

How your data stays yours
  • No account

    Open the app and start. We never ask who you are.

  • On-device

    Your data is stored and encrypted on your phone.

  • No analytics SDKs

    No Firebase, no trackers, no ad networks.

  • Open by design

    A verifiable, auditable foundation — not just a promise.

Questions

Retatrutide, tracked privately

Is retatrutide FDA-approved or available?

Not yet. As of 2026 retatrutide is in Phase 3 trials and is not FDA-approved. Lirea does not sell or supply it or any medication — it's a private tracker for people who are taking something, however they obtained it.

Why track retatrutide if it isn't approved yet?

People in trials, and people using research-sourced material, still want an accurate private record of doses, weight, and side effects. Lirea keeps that history on your device, with no account.

How much weight loss does retatrutide show in trials?

Reported trial results are among the highest in the class. We don't quote a number as a promise — results vary, and the drug is still under review.

Related trackers

Lirea is a private tracking tool, not a medical device, a pharmacy, or a source of medical advice. Anything shown here is general reference, not a recommendation. Always follow the guidance of a qualified healthcare provider.

Start privately

Your shot. Your data. Your device.

Track your weekly dose, your titration, and how you’re feeling — all on your device. No account required.

Coming soon to iOS and Android.